INAB (IN8bio) Insider Ownership: 4.94 % (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INAB IN8bio Inc INAB
27 GF Score
Price $1.18
View Full Analysis

What is IN8bio Insider Ownership?

IN8bio INAB -7.81% 27 Insider Ownership is 4.94 % as of Aug. 25, 2026. GuruFocus rates INAB with a GF Score™ of 27/100.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, IN8bio's insider ownership is 4.94%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, IN8bio's Institutional Ownership is 38.11%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, IN8bio's Float Percentage Of Total Shares Outstanding is 89.34%.

IN8bio Insider Ownership Historical Data

* Premium members only.

The historical data trend for IN8bio's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IN8bio Insider Ownership Chart

IN8bio Historical Data

The historical data trend for IN8bio can be seen below:

2025-05-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30 2026-07-31
Insider Ownership 4.35 87.07 87.07 87.07 87.07 4.99 4.99 4.94 4.94 4.94
INAB
27GF Score
IN8bio Inc INAB
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IN8bio Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 4.94 % mean?
IN8bio (INAB) has a Insider Ownership of 4.94 % as of Aug. 25, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on IN8bio and its competitors.
Is IN8bio's Insider Ownership too high?
IN8bio's current Insider Ownership is 4.94 %. Overall, IN8bio has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does IN8bio's Insider Ownership compare to INTS and CALC?
IN8bio's Insider Ownership of 4.94 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on IN8bio and its competitors. IN8bio's current Insider Ownership is 4.94 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IN8bio stock overvalued right now?
IN8bio (INAB) has a current Insider Ownership of 4.94 %. The current Insider Ownership is 4.94 %. IN8bio's overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For IN8bio (INAB), the current Insider Ownership is 4.94 % as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IN8bio Business Description

Other Exchanges 6JH0:Germany
Address 350 5th Avenue, Suite 5330, New York, NY, USA, 10118
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.
27GF Score

Get the complete analysis for INAB

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.18
Price